Impact Of CSI-Style Programming On Jurors: How Attitudes And Expectations May Impact On Jurors' Decision-Making In A Courtroom A new psychological study from the University of Leicester aims to investigate how accurate people's perceptions about forensic science are, where these beliefs come from, and how this forensic awareness may impact on jury decision making.
Source: www.medicalnewstoday.comMajor Nanotech, Energy, And Biomed Meeting Next month in Boston, the AVS 55th International Symposium & Exhibition will showcase research from across the spectrum of science and engineering devoted to discoveries on the edge - in a vacuum, at interfaces, in plasmas, and in other controlled environments used to develop new materials and technologies.
Source: www.medicalnewstoday.comTakeda Submits A New Drug Application In The U.S. For Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) For The Treatment Of Type 2 Diabetes Takeda Pharmaceutical Company Limited (Takeda) announced that its wholly owned subsidiary, Takeda Global Research & Development Center, Inc. (U.S.), submitted a New Drug Application (NDA) to the U.S.
Source: www.medicalnewstoday.comEstablished Safety Profile Of Spiriva Confirmed By 30 Rigorously Controlled Clinical Trials And The Landmark Trial UPLIFT Boehringer Ingelheim and Pfizer Inc have released a new analysis of 30 rigorously controlled clinical trials, including UPLIFT, confirming the long term safety profile of Spiriva(R) HandiHaler(R) (tiotropium bromide inhalation powder). The new and expanded safety data contradicts the conclusions about tiotropium in an article by Singh et al.
Source: www.medicalnewstoday.comIDM Pharma Provides Update On Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting Of European Committee For Medicinal Products IDM Pharma, Inc.
Source: www.medicalnewstoday.com
# posted by Network @ 2:00 PM
